No, Keytruda isn’t a chemotherapy drug. It’s an immunotherapy drug. Chemotherapy is a type of cancer treatment that kills cancer cells or stops them from multiplying (making more cells).
Merck & Co is pressing home its precious advantage in first line non-small cell lung cancer, with new data from a Keytruda + chemo combination suggesting patients' lives could be significantly ...
GlobalData on MSN1mon
FDA approves MSD’s KEYTRUDA as first-line MPM treatmentThe US Food and Drug Administration (FDA) has approved MSD’s KEYTRUDA regimen as a first-line treatment for adults with ...
Results also showed a two-year progression-free survival rate of 48% with Keytruda compared with 19% with chemotherapy. There was also an improved overall response rate with Keytruda of 43.8% ...
KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...
This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.
An anti-programmed death receptor-1 (PD-1) therapy, the treatment is indicated for use in combination with pemetrexed and platinum chemotherapy. The approval for the KEYTRUDA regimen is supported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback